Related Experiment Videos

myc and E1A oncogenes alter the responses of PC12 cells to nerve growth factor and block differentiation

K Maruyama1, S C Schiavi, W Huse

  • 1Center for Cancer Research, Massachusetts Institute of Technology, Cambridge 02139.

Oncogene
|January 1, 1987
PubMed

Insights

Nuclear oncogenes Myc and E1A block nerve growth factor (NGF)-induced neuronal differentiation in PC12 cells. These oncogenes redirect NGF

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Neuroscience

Background:

  • PC12 rat pheochromocytoma cells differentiate and arrest growth upon nerve growth factor (NGF) stimulation.
  • Understanding the molecular mechanisms regulating cell fate decisions in response to growth factors is crucial.

Purpose of the Study:

  • To investigate the impact of nuclear oncogenes, mouse c-myc and adenovirus E1A, on NGF-mediated neuronal differentiation in PC12 cells.
  • To determine if these oncogenes alter the cellular response to NGF at a pre- or post-receptor level.

Main Methods:

  • Introduction of mouse c-myc and adenovirus E1A genes into PC12 cells.
  • Assessment of morphological differentiation and cell proliferation in response to NGF.
  • Analysis of NGF receptor binding and ornithine decarboxylase induction.

Main Results:

  • Expression of c-myc or E1A inhibited NGF-induced morphological differentiation in PC12 cells.
  • NGF stimulated cell proliferation in oncogene-expressing cells, contrasting with growth arrest in wild-type cells.
  • NGF receptor binding and ornithine decarboxylase induction remained comparable, indicating post-receptor alterations.

Conclusions:

  • Nuclear oncogenes c-myc and E1A can override NGF's differentiation-promoting signal, favoring proliferation.
  • These oncogenes modify the intracellular signaling pathways downstream of the NGF receptor.
  • The study highlights the plasticity of PC12 cell responses to growth factors and hormones, influenced by oncogene expression.

Related Concept Videos